PRTG PORTAGE BIOTECH INC

Portage Biotech to Participate in Panel Discussion at the Cantor Global Healthcare Conference

Portage Biotech to Participate in Panel Discussion at the Cantor Global Healthcare Conference

WESTPORT, Conn., Sept. 20, 2023 (GLOBE NEWSWIRE) -- Portage Biotech Inc. (NASDAQ: PRTG), a clinical-stage immuno-oncology company advancing novel multi-targeted therapies for use as single agents and in combination, today announced that the Company’s management team will participate in a panel discussion at the Cantor Global Healthcare Conference on Thursday, September 28, 2023 at 10:20 – 10:50 AM ET in New York, NY.

The Portage management team will participate in one-on-one investor meetings during the event. Investors interested in meeting with Portage at the conferences should contact their Cantor representative.

About Portage Biotech Inc.

Portage is a clinical-stage immuno-oncology company advancing multi-targeted therapies to extend survival and significantly improve the lives of patients with cancer. Lead programs in the Portage portfolio include first-in-class invariant natural killer T cell (iNKT) small molecule engagers and best-in-class adenosine antagonists. These programs are being advanced using innovative trial designs and translational data to identify the patient populations most likely to benefit from treatment. The Company’s unique business model leverages a strong network of academic experts and large pharma partners to rapidly and efficiently advance multiple products. For more information, please visit , follow us on Twitter at @PortageBiotech or find us on LinkedIn at Portage Biotech Inc.

FOR MORE INFORMATION, PLEASE CONTACT:

Investor Relations

Chuck Padala



EN
20/09/2023

Underlying

PRTGPORTAGE BIOTECH INC

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on PORTAGE BIOTECH INC

 PRESS RELEASE
Free
PRTG PORTAGE BIOTECH...

Meet Vera Report, The App That Lets You Whistleblow Anonymously From a...

Meet Vera Report, The App That Lets You Whistleblow Anonymously From a Smartphone Using Telegram Messenger Vera Report enables real-time, anonymous reporting of fraud, waste, and abuse with an intelligent privacy layer providing secrecy and protection for whistleblowers Washington, DC, USA, March 03, 2026 (GLOBE NEWSWIRE) -- AlphaTON Capital Corp. (Nasdaq: ATON) and the Midnight Foundation today announced the unveiling of Vera Report, the world's first anonymous reporting platform built on privacy-preserving blockchain technology and confidential compute. Confidential compute means subm...

21h / 55m 1 EN
 PRESS RELEASE
Free
PRTG PORTAGE BIOTECH...

AlphaTON Capital Strengthens Engineering Core with Appointment of TON ...

AlphaTON Capital Strengthens Engineering Core with Appointment of TON Ecosystem Visionaries Aleksej Paschenko and Andrei Pfau LISBON, PORTUGAL, March 02, 2026 (GLOBE NEWSWIRE) -- AlphaTON Capital Corp. (Nasdaq: ATON), the leading public technology company scaling the Telegram super-app and decentralized AI infrastructure, today announced the appointment of Aleksej Paschenko and Andrei Pfau as Senior Engineers. As AlphaTON accelerates its mission to provide privacy-preserving infrastructure for Telegram’s 1 billion monthly active users, these dual hires signal a major leap in technical ca...

March 2, 2026 1 EN
 PRESS RELEASE
Free
PRTG PORTAGE BIOTECH...

AlphaTON Capital Releases Market Update on Outstanding Shares, Warrant...

AlphaTON Capital Releases Market Update on Outstanding Shares, Warrants, Options, and RSUs Road Town, Tortola, British Virgin Islands, Feb. 19, 2026 (GLOBE NEWSWIRE) -- AlphaTON Capital Corp. () ("AlphaTON" or the "Company"), the world's leading public technology company scaling the Telegram super-app with an addressable market of one billion monthly active users, today announced a market update on its outstanding shares, warrants, options, and RSUs. As of February 19, 2026, the Company has outstanding: 23,434,588 ordinary shares 1,373,686 ordinary shares issuable upon the exercise of ou...

February 19, 2026 1 EN
 PRESS RELEASE
Free
PRTG PORTAGE BIOTECH...

Brittany Kaiser, CEO of AlphaTON Capital ($ATON), Goes Live on X to Re...

Brittany Kaiser, CEO of AlphaTON Capital ($ATON), Goes Live on X to Reveal the Strategy Behind Recent AI Infrastructure Play San Juan, Puerto Rico, USA, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Brittany Kaiser, whistleblower, data rights pioneer, and the CEO of AlphaTON Capital (NASDAQ: ATON), joins Mario Nawfal X Space for a live conversation on confidential AI access and why everyone needs to own their digital identity. For the first time, she will reveal the strategy behind AlphaTON's GPU acquisition playbook, the infrastructure powering Cocoon AI (Telegram’s AI), and why this Nasdaq list...

February 18, 2026 1 EN
 PRESS RELEASE
Free
PRTG PORTAGE BIOTECH...

AlphaTON Capital Executes Binding Call Option to Sell Legacy Biotech A...

AlphaTON Capital Executes Binding Call Option to Sell Legacy Biotech Asset iOx Therapeutics to Immunova Structure Preserves Shareholder Upside Through Equity, Milestones, Royalties, and Sublicensing Participation Dover, DE, Feb. 17, 2026 (GLOBE NEWSWIRE) -- AlphaTON Capital Corp. ( ("AlphaTON" or the "Company"), the world's leading public technology company scaling the Telegram super app for an addressable market of over 1 billion monthly active users, today announced the execution of a binding call option agreement with Immunova, LLC ("Immunova"), granting Immunova, or an affiliate, th...

February 17, 2026 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch